ArticleProceedings of the National Academy of Sciences of the United States of America2019
Predicting clinical outcome of therapy-resistant prostate cancer.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Molecular mechanisms and classification of castration-resistant prostate cancer: Insights into androgen receptor, cancer stem cells, and neuroendocrine features.Current urology · 2026Article
- Strategies to target the cancer driver MYC in tumor cells.Frontiers in oncology · 2023Review
- Global research trends and foci of artificial intelligence-based tumor pathology: a scientometric study.Journal of translational medicine · 2022Article
- The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide.BMC cancer · 2022Article
- Development of a novel five-gene immune-related risk model for the prognosis evaluation of prostate adenocarcinoma patients.American journal of cancer research · 2022Article
- The Global Research of Artificial Intelligence on Prostate Cancer: A 22-Year Bibliometric Analysis.Frontiers in oncology · 2022Article
- UrinaryEXCLI journal · 2020Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.